Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
See Latest ArticlesHome Buprenorphine/Naloxone Induction in Primary Care
Journal of General Internal Medicine, 12/22/08
Lee JD et al. - Home buprenorphine induction was feasible and appeared safe. Induction complications occurred at expected rates and were not associated with short-term treatment drop-out.
Related Articles
Low doses of transdermal buprenorphine in opioid-naive patients with cancer pain: A 4-week, nonrandomized, open-label, uncontrolled observational study
Clinical Therapeutics, 11/19/09
Relevance Score: 87%
Why Do the Clients of Georgian Needle Exchange Programmes Inject Buprenorphine
European Addiction Research, 11/05/09
Relevance Score: 85%
Purdue Pharma L.P. Presents Phase 3 Study of Transdermal Delivery of Buprenorphine in Moderate to Severe Pain
Purdue, 11/24/09
Relevance Score: 83%
Today in Substance Abuse...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of co-occurring disorders and intimate partner violence on substance abuse treatment outcomes
Journal of Substance Abuse Treatment, 02/09/10
The Dual Diagnosis Physician-infrastructure Assessment Tool: Examining Physician Attributes and Dual Diagnosis Capacity
Psychiatric Services, 02/09/10
A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers
Drug and Alcohol Dependence, 02/09/10
Article Search
Sponsor
Sponsor